TI
GILD icon

Telemetry Investments’s Gilead Sciences GILD Stock Holding History

Telemetry Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,000
Closed -$3.4M – 117
2017
Q1 		$3.4M Buy
+50,000
New +$3.52M 1.52% 13
2015
Q3 		– Sell
-40,000
Closed -$4.68M – 139
2015
Q2 		$4.68M Buy
+40,000
New +$4.37M 2.11% 14

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments's GILD Position: Q3 2016 in Review

Telemetry Investments sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 2,500 shares — an estimated $209K sold.

Telemetry Investments first reported a position in GILD in Q1 2016 and held it in 2 quarters. The position peaked at $551K in Q1 2016. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Telemetry Investments reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Telemetry Investments sold 2,500 Gilead Sciences shares in Q3 2016, an estimated $209K.
  • Telemetry Investments first reported a position in Gilead Sciences in Q1 2016 and held it in 2 quarters.
  • Telemetry Investments's Gilead Sciences position peaked at $551K in Q1 2016.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Telemetry Investments's 13F filing for Q3 2016, filed 14 Nov 2016.